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The aim of the study was to determine the right storage
and transport conditions for blood and serum samples
intended for later selenium measurements. Blood and
serum samples were stored in different temperature con-
ditions (+4°C and -20°C). After 3, 7 and 14 days the sele-
nium level was measured in each sample and the results
were compared with the initial selenium level. Selenium
was quantitatively measured using graphite furnance
atomic absorption spectrometry (GF-AAS) with Zeeman
correction (AAnalyst 600, PerkinElmer).
Storage of whole blood samples in -20°C occurred to be
inappropriate. Centrifugation of serum for the measure-
ment was not possible even after the shortest time of
incubation. However, samples stored at +4°C were mea-
sured and analyzed. After the period of 3, 7 and 14 days
the selenium level in the sample was higher than initially
(7%, 11% and 24% respectively). On the other hand,
neither the temperature nor the time of storage of centri-
fuged serum samples had any influence on selenium
level. In all analyzed cases the selenium level did not dif-
fer more than 10% of initial level.
The experiment clearly showed how blood or serum
samples should be stored before the measurement to
obtain correct and repeatable results of selenium level.
The experiment will be also very helpful in creation of a
set of rules for laboratories in different places in Poland
and Europe for proceeding with samples after collection
to assure the highest quality of results.
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